Aedes aegypti and Aedes albopictus are the key transmitters of varied life-threatening arbovirus diseases; overuse of synthetic chemicals to target vector-borne diseases has an adverse impact on the environment. Biological agents have proven to be an alternative source to synthetic agents for controlling mosquitoes. In this context, the present study investigated the biosynthesis of ZnO NPs using Solanum lycopersicum leaf extract under the influence of solution combustion synthesis method and assessment of its larvicidal efficacy against Aedes aegypti. Synthesised ZnO NPs were characterised by using UV–vis, FTIR, SEM, EDX and XRD. The physicochemical parameter confirmed the synthesised nanoparticles were highly pure. The UV spectrum showed a strong peak at 352 nm corresponding to bandgap energy 3.01 eV. The SEM indicates the particles were rod-like structures. Further, the EDX analysis primarily confirms the zinc and oxygen without any impurities. The XRD data shows the crystallite size of ZnO Nps was of 40.93 nm. Finally, the aqueous leaf extract and ZnO NPs showed significant (p < 0.05) larvicidal activity at 48 h. However, ZnO NPs revealed high larvicidal effect compared to aqueous extract. From the results, it can be concluded that the bioactive constituents present within the plant extract act as capping and reducing agents for the successful ZnO NPs synthesis and could be used for controlling mosquito vector Ae. aegypti.
26 July 2024 in Journal of the Iranian Chemical Society
Objective: We aimed to develop a novel heterocyclic compound incorporating both indole and pyrazole moieties to assess its antidiabetic properties, as most existing antidiabetic medications, such as acarbose, voglibose, and miglitol, lack these specific structural features. Methods: The newly synthesized sulfonamide-based indole and pyrazole derivatives were characterized using mass spectrometry, 1H, 13C NMR, IR, and techniques. In vitro and in vivo studies were conducted using Drosophila melanogaster as a model organism to evaluate toxicity and antidiabetic activity. Molecular modeling studies were performed using Sybyl-X, version 2.0. Results and Discussion: The results indicate that compound (C-04) (IC50 = 83.87 µM for α-amylase and IC50 = 73.15 µM for α-glucosidase) and compound (IVb) (IC50 = 63.34 µM for α-amylase and IC50 = 80.92 µM for α-glucosidase) exhibited significant enzyme inhibitory activities compared to acarbose, the positive control (IC50 = 35.17 µM). In addition, ADME properties of the synthesized compounds were analyzed using the SwissADME online tool. Further research can be conducted on compounds (IVb) and (C-04) to explore their potential as novel antidiabetic treatments by systematically increasing the dose, which may enhance their therapeutic efficacy. Conclusions: The findings suggest that compounds (C-04) and (IVb) hold promise for further development and could potentially undergo clinical trials in the future.